Book Review: Regulation of the Pharmaceutical Industry,edited by J. Abraham and H.L. Smith and Personalised Medicine,by A. Hedgecoe

Angell, M. 2004. The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.

Levy, E. 2005. Assessing drug development reforms in Angell’s “The truth about the drug companies: How they deceive us and what to do about it.” CAE Electronic Working Papers Series no. CAE 003. http://www.ethics.ubc.ca/workingpapers/cae/cae003.pdf (accessed December 10, 2006).

Marden, E. , H. Longstaff , and E. Levy . Forthcoming. Transgenic salmon: Regulatory oversight of an anticipated technology. In Emerging technologies, edited by E. F. Einsiedel . Vancouver: University of British Columbia Press.

Marden, E. , and D. Nelkin . 2000. Displaced agendas: Current regulatory strategies for germline gene therapy. McGill Law Review 45: 461-481.